The Coalition for Epidemic Preparedness Innovations (CEPI) has pledged to facilitate the development of new vaccines within 100 days of a new pathogen with epidemic or pandemic potential being identified, but meeting this ambitious timeline will require significantly faster processes.
To deliver on its “100-Days Mission,” an initiative backed by G7 and G20 nations and first proposed in June 2021, CEPI has entered four international partnerships that will focus specifically on using
Key Takeaways
-
AI could help researchers to identify antigens for known viruses and create a library of virtual antigen designs, reducing early research timelines from a year or more to just weeks.
-
The use of AI in other drug and vaccine R&D settings, such as clinical trials, is also being explored
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?